• $3.7M
    Market Cap
  • -88.02%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
0
-100.00%
7,500
-98.91%
686,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
7,500
-98.91%
686,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.8M
+2.38%
-4.7M
+24.00%
-3.8M
N/A
Depreciation and Amortization Expense
138,069
+5.25%
131,188
+1.18%
129,653
N/A
Total Operating Expenses
11.0M
-0.24%
11.0M
+32.40%
8.3M
N/A
Operating Profit
-11.0M
-0.17%
-11.0M
+44.23%
-7.6M
N/A
Interest Income
70,209
-42.71%
122,553
+7,671.27%
1,577
N/A
Interest Expense
N/A
N/A
0
+100.00%
-167,726
N/A
Interest Income and Expense and Net
70,209
-42.71%
122,553
+173.76%
-166,149
N/A
Total Nonoperating Income and Expense
19,614
-99.03%
2.0M
+155.52%
-3.7M
N/A
Income before Taxes
-10.9M
+22.20%
-9.0M
-20.49%
-11.3M
N/A
Income Taxes
8,319
-7.88%
9,031
-47.82%
17,308
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-11.0M
+22.17%
-9.0M
-20.53%
-11.3M
N/A
Net Income from Continuing Operations Applicable to Common
-10.9M
+22.07%
-9.0M
-29.05%
-12.6M
N/A
Basic EPS and Net Income
-2.25
-5.06%
-2.37
+29.51%
-1.83
N/A
Diluted EPS and Net Income
-2.25
-5.06%
-2.37
+29.51%
-1.83
N/A
Basic Weighted Average Shares
4.9M
+28.78%
3.8M
-45.35%
6.9M
N/A
Diluted Weighted Average Shares
4.9M
+28.78%
3.8M
-45.35%
6.9M
N/A
Balance Sheet
Cash and Cash Equivalents
2.1M
-54.59%
4.6M
+153.61%
1.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.1M
-54.59%
4.6M
+153.61%
1.8M
N/A
Total Current Assets
3.0M
-42.25%
5.2M
+106.20%
2.5M
N/A
Accumulated Depreciation
633,045
+22.92%
515,003
+28.11%
401,987
N/A
Property and Plant and Equipment and Net
548,591
-16.11%
653,957
-7.90%
710,075
N/A
Total Long-Term Assets
47,402
+0.98%
46,941
-1.71%
47,760
N/A
Total Assets
5.0M
-31.71%
7.4M
+43.85%
5.1M
N/A
Income Taxes Payable
6,256
-45.94%
11,572
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
4.5M
N/A
Total Current Liabilities
1.1M
-22.38%
1.4M
-14.18%
1.6M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
156,190
-49.94%
312,019
-45.54%
572,976
N/A
Total Liabilities
1.2M
-26.28%
1.7M
-24.60%
2.2M
N/A
Retained Earnings
-68.5M
+19.03%
-57.6M
+18.45%
-48.6M
N/A
Total Stockholders Equity
3.8M
-33.29%
5.7M
+95.61%
2.9M
N/A
Total Shares Outstanding
10.7M
+40.84%
7.6M
-36.96%
12.1M
N/A
Cash Flow
Cash from Operating Activities
-11.2M
+10.22%
-10.2M
+38.32%
-7.4M
N/A
Capital Expenditures
24,213
+182.57%
8,569
-67.72%
26,544
N/A
Cash from Investing Activities
-182,909
-51.77%
-379,246
+19.16%
-318,259
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
8.9M
-33.04%
13.3M
+122.62%
6.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-146,468.53%
N/A
N/A
N/A
Return on Assets
-176.93%
+23.06%
-143.78%
N/A
N/A
N/A
Return on Equity
-230.65%
+10.75%
-208.27%
N/A
N/A
N/A
Revenue Growth
-100.00%
+1.11%
-98.91%
N/A
N/A
N/A
Current Ratio
2.83
-25.60%
3.80
N/A
N/A
N/A
Cash Ratio
1.94
-41.50%
3.31
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow